← Back to headlines
Johnson & Johnson Leverages AI to Accelerate Drug Development
Johnson & Johnson is utilizing artificial intelligence to significantly reduce the time required to identify promising chemical compounds and biologics for drug development, according to CIO Jim Swanson.
28 Apr, 04:16 — 28 Apr, 04:16
